Back to the WireSEC EDGAR
ConfirmedSEC EDGAR ·
Larimar Therapeutics, Inc. files an 8-K: Results of Operations and Financial Condition
From the filing
Item 2.02: Results of Operations and Financial Condition; Item 9.01: Financial Statements and Exhibits
Items listed in the filing. The full text is at SEC EDGAR.
Who is reporting it
- GlobeNewswirefirst at Nov 16, 2026, 4:00 AM ESTRead at GlobeNewswire (opens in a new tab)
- SEC EDGARfirst at Nov 16, 2026, 6:01 AM ESTRead at SEC EDGAR (opens in a new tab)
- PR Newswirefirst at Nov 16, 2026, 6:30 AM ESTRead at PR Newswire (opens in a new tab)
- Seeking Alphafirst at Nov 16, 2026, 7:10 AM ESTRead at Seeking Alpha (opens in a new tab)
Story so far
Reported by 5 sources
On November 16, 2026, a run of companies released third quarter 2026 results, including Niu Technologies, iQIYI, XPENG, KE Holdings, H World Group, 22nd Century Group, TOYO, and GT Biopharma.
- Nov 16, 2026, 4:00 AM EST · GlobeNewswireConfirmedNiu Technologies Announces Unaudited Third Quarter 2026 Financial Results
- Nov 16, 2026, 4:00 AM EST · GlobeNewswireConfirmediQIYI Announces Third Quarter 2026 Financial Results
- Nov 16, 2026, 4:40 AM EST · GlobeNewswireConfirmedXPENG Reports Third Quarter 2026 Unaudited Financial Results
- Nov 16, 2026, 5:00 AM EST · GlobeNewswireConfirmedKE Holdings Inc. Announces Third Quarter 2026 Unaudited Financial Results
- Nov 16, 2026, 5:15 AM EST · GlobeNewswireConfirmedH World Group Limited Reports Third Quarter of 2026 Unaudited Financial Results
- Nov 16, 2026, 6:00 AM EST · GlobeNewswireConfirmed22nd Century Group Reports Third Quarter 2026 Financial Results
- Nov 16, 2026, 6:01 AM EST · SEC EDGARConfirmedSilexion Therapeutics Corp files an 8-K: Results of Operations and Financial Condition
Comments
Log in or create a free account to comment.
No comments yet.
The headline links to the original source; the summary is written by The Market Standard. Nothing here is financial advice.